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Rapid tumor induction in zebrafish 
by TALEN-mediated somatic 
inactivation of the retinoblastoma1 
tumor suppressor rb1
Staci L. Solin1, Heather R. Shive2, Kevin D. Woolard3, Jeffrey J. Essner1 & Maura McGrail1
Investigating the in vivo role of tumor suppressor genes in cancer is technically challenging due 
to their essential requirement during early animal development. To address this bottleneck, we 
generated genetic mosaic adult zebrafish using TALEN genome editing and demonstrate somatic 
inactivation of the tumor suppressor retinoblastoma1 (rb1) induces tumorigenesis at high frequency. 
11–33% of 1-cell stage embryos injected with TALEN mRNAs targeting rb1 exon 2 or 3 develop 
tumors beginning as early as 3.5 months of age. Lesions predominantly arise in the brain and show 
features of neuroectodermal-like and glial-like tumors. Mutant allele analysis is consistent with tumor 
initiation due to somatic inactivation of rb1, revealing a conserved role for rb1 in tumor suppression 
across vertebrates. In contrast to genetic mosaics, heterozygous rb1−/+ adults show no evidence 
of neoplasia, while homozygous mutant rb1−/− are larval lethal. This is the first demonstration 
that somatic inactivation of a tumor suppressor causes cancer in zebrafish, and highlights the utility 
of site-specific nucleases to create genetic mosaic zebrafish for tumor suppressor gene discovery. 
Somatic inactivation with site-directed nucleases in zebrafish presents a rapid and scalable strategy 
to study tumor suppressor gene function in cancer.
Targeted somatic inactivation of tumor suppressor genes in genetic mosaic animals enables investigation 
of their roles in carcinogenesis if they are embryonic lethal. Mouse and zebrafish models of human 
cancer frequently require crosses with multiple transgenic lines to create conditional gene knockouts in 
predisposed mutant backgrounds1–4. Genome editing nucleases are emerging as a highly efficient alterna-
tive strategy for inactivating gene function in somatic tissues. TAL effector nucleases (TALENs) were first 
used for somatic gene inactivation to study vascular system development in zebrafish embryos5. Adult 
phenotypes have also been created in zebrafish and mice with CRISPR/Cas9 nuclease genome editing. In 
zebrafish, tissue specific CRISPR/Cas9s have been used for targeted gene knockout in the hematopoietic 
system6. Nuclease targeted somatic inactivation was successfully used in adult mice to investigate coop-
erating genes during liver and lung carcinogenesis7,8. Most recently, malignant brain tumor models were 
developed using CRISPR/Cas9 somatic inactivation of multiple tumors suppressors in embryonic and 
neonatal mouse brain9. Multiplex gene targeting with site directed nucleases simplifies the process of cre-
ating complex genotypes that normally require numerous genetic crosses. In addition, targeting nucleases 
allow for introduction of a range of loss of function alleles in addition to complete gene knockouts10,11.
The central role of the retinoblastoma tumor suppressor Rb1 in human cancer is well established. 
The Rb protein family’s main tumor suppressive role is in regulation of cell cycle entry through inter-
action with E2F transcription factors12. Rb1 function also intersects with pathways controlling cellular 
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senescence, apoptosis, DNA repair, and chromosome integrity13,14. Mutation or alteration of the Rb1 
pathway is detected in the majority of human adult gliomas15,16. The role of Rb1 in specific cancers 
has been studied in mice by germline mutation17,18 and somatic inactivation with conditional or tissue 
specific knockouts19,20. Targeted and conditional knockout of Rb1 in combination with tp53, PTEN, or 
Nf1 tumor suppressors in astrocytes and neural progenitors in adult mice induces malignant brain tum-
ors21–26, consistent with the predicted role for these genes in preventing cellular transformation in pro-
genitor cell populations in the brain. Combinatorial deletion of tumor suppressors with or without Rb1 
was shown to influence brain tumor phenotypes, indicating genetic disruption of cell cycle regulation in 
progenitors favors formation of primitive neuroectodermal tumors over glioma26.
Here we present a proof of principle study in zebrafish that shows genome editing nucleases can be 
used to study tumor suppressor gene function by targeted somatic inactivation. We demonstrate that 
TALEN-mediated targeting of rb1 results in highly penetrant tumor formation in genetic mosaic adults. 
The zebrafish rb1 tumor suppressor is an essential gene that functions in retinal neural progenitor prolif-
eration and cell fate specification27. However, its role in cancer has not been previously studied in zebraf-
ish. Heterozygous adult fish with stable germline rb1 frameshift alleles did not develop lesions or tumors. 
In contrast, genetic mosaic adults develop tumors, predominantly in the brain, with varying degrees 
of proliferation and histological features of neuroectodermal-like or glial-like tumors. The majority of 
mutant rb1 alleles in somatic, germline and brain tumor tissues were frameshift mutations. In tumor 
tissue only one or two frameshift alleles were present and overrepresented compared to wild type tissue. 
Together, the data indicate that biallelic inactivation of rb1 in somatic tissue underlies neoplastic trans-
formation and tumor initiation. Predisposing zebrafish to brain tumors by somatic inactivation of rb1 
with site-specific nucleases will be useful for investigating pathways cooperating in brain tumorigenesis. 
Nuclease gene targeting in zebrafish presents a rapid and simple method to screen potentially hundreds 
of candidate tumor suppressor genes that impact carcinogenesis.
Results and Discussion
We used TALEN targeting to isolate germline mutations in the zebrafish retinoblastoma1 (rb1) tumor 
suppressor gene. Single cell embryos were injected with 150 or 200 pg of TALEN mRNA targeting rb1 
exon 2 or 12.5 to 50 pg of TALEN mRNA targeting rb1 exon 3 (Supplementary Figure S1). rb1 exon 2 
TALENs were highly efficient, obtaining up to 100% biallelic inactivation in 50% of injected embryos. 
Lower mutagenesis efficiency was observed with rb1 exon 3 TALENs, and increased doses caused high 
toxicity and mortality. We screened three adults for germline transmission and recovered four new 
rb1 alleles in exon 2, two frameshift deletions Δ4 and Δ7, and two in frame deletion Δ9 and Δ12 
(Supplementary Figure S1). Homozygous Δ4 and Δ7 larvae failed to develop a swim bladder and died 
at ~7 days post fertilization, as reported previously for the rb1 mutant space cadet27. Normal development 
and viability was observed in the in frame deletion Δ9 and Δ12 homozygotes.
During the course of this study, we observed that the genetic mosaic adults generated by somatic 
inactivation of rb1 in embryos develop tumors in the head region at high frequency (Fig. 1). Beginning 
at 3.5 months of age, fish that were injected with rb1 TALENs as embryos presented with tissue masses 
protruding out over the eyes and causing malformation of the skull (Fig. 1b, arrows). At 1.5 years post 
fertilization, tumor penetrance in rb1 exon 2 and exon 3 TALEN injected fish was 33% (29/87 adults) and 
11% (29/275), respectively (Table 1). The heads from 52/58 adults were dissected and revealed abnormal 
brain morphology disrupted by large masses. The remaining 6 adults with lesions in the head region 
were not further analyzed (Table  1, “unknown”). Adults often displayed abnormal swimming behavior 
before overt appearance of masses in the head region, providing an early indicator of brain lesions in the 
affected animal. In contrast, heterozygous rb1−/+ adults carrying either of the established rb1 frameshift 
alleles do not develop tumors and are behaviorally normal.
Serial sections of 14/52 dissected brains in eight exon 2-targeted and six exon 3-targeted fish revealed 
12 neoplastic mass lesions that infiltrated and effaced the neuropil and two brains with expanded glial 
rests (Table  1). The remaining dissected brains were not analyzed by histology for tumor character-
ization (Table  1 “not analyzed by histology)”. Most tumors exhibited numerous mitoses and variable 
numbers of individually apoptotic cells. Prominent vasculature was generally not a feature of individual 
tumors. Tumors exhibited a range of histological features (Fig.  2 and Table  1), but the majority (7/12) 
exhibited histological features suggestive of neuroectodermal-like tumors, including hyperchromatic or 
oval/wedge-shaped nuclei with rosette formation (Fig. 2a,b) or multilayered tubular structures (Fig. 2c). 
Four of 12 tumors contained features more consistent with glial-like tumors (Fig. 2d) or mixed glial-like 
tumors (Fig. 2e). The remaining two brains revealed proliferative cell populations that appeared to arise 
from glial rests (glial cells that are retained from embryonal neurogenesis), without formation of a clear 
mass lesion (Fig. 2f).
Two brain tumors from exon 2 and exon 3 targeted fish were analyzed by immunohistochemistry 
for identification of proliferating cells and expression of glial and neuronal markers. Consistent with 
the observation of mitotic figures in hematoxylin and eosin sections (Fig.  2d), many cells expressing 
phospho-histone H3 were observed in different regions of each tumor (Fig. 3d,e; Supplementary Figure 
2). In one brain, the overall structure appeared mostly normal, but the lateral division of the valvula 
cerebelli contained numerous proliferating cells not observed in wild type (Supplementary Figure 2). 
Images of glial and neuronal differentiation markers labeling wild type brain and a representative brain 
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tumor are shown in Fig. 3. The glial marker S100 and neuronal markers HuC/D and SV2 were detected 
within less disrupted regions of the tumor positive brain including the parenchyma (Fig. 3g,j,m), which 
may represent non-neoplastic cells. These regions frequently showed infiltration of neoplastic cells 
(Fig. 3g,j,m). Expression of S100 within densely cellular regions of the tumors was limited to a few cells 
with similar appearance to astrocytes (Fig. 3h), although the presence of stellate astrocytes in the mid-
brain of adult zebrafish has not been reported28. Little to no expression of neuronal markers HuC/D and 
SV2 was observed in these tumor regions (Fig. 3k,n). The lack of expression of differentiation markers 
for glia (S100) and neurons (HuC/D and SV2) suggests the tumors may lack differentiated cell types, but 
this is not definitive. Together, the data suggest that somatic inactivation of rb1 results in brain tumors 
that are highly infiltrative with diverse histological features.
Figure 1. Somatic inactivation of rb1 predisposes adult zebrafish to central nervous system tumors. 
(a) TALEN mRNAs targeting exon 2 or exon 3 of rb1 injected into 1-cell stage zebrafish embryos induces 
genetic mosaicism in somatic tissue and brain tumors in adults. Mosaic embryos with variable grey shading 
of individual cells representing one of n possible rb1 alleles. Adults with genetic mosaic tissue represented 
by grey areas. Red circles represent brain lesions. (b) Presentation of cranial tumors in three 8 month old 
adult zebrafish injected with rb1 TALENs as 1-cell embryos. Age matched adult wild type fish is shown for 
comparison. Arrows point to masses protruding out of the cranial cavity over the eyes and distorting the 
dorsal head region.
TALEN-targeted rb1 exon
Tumor number and 
frequency (%)a
Tumor location and 
histological features Number
Exon 2b 29/87 (33%) Brain 23/29
glial or glial/neuronal 1
 expanded glial rests 2
neuroectodermal-like 5
not analyzed by histologyc 15
Unknownd 6/29
Exon 3e 29/275 (11%) Brain 29/29
glial or glial/neuronal 3
neuroectodermal-like 3
not analyzed by histologyc 23
Control un-injectedf 0/150 – –
Table 1. Tumor frequency and location in adult zebrafish after somatic inactivation of rb1. aFrequency 
and percentage of adult fish with tumors at 1.5 years of age. bFour separate injections of 150 pg or 200 pg. 
cAdults presenting with gross tumors in head region; morphology of dissected brain was abnormal and 
disrupted by mass lesion; histopathology not performed. dTumors located in head region; dissection and 
histopathology not performed. eThree separate injections of 12.5, 25, or 50 pg. fControl un-injected fish 
raised alongside TALEN-injected embryos.
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The frequency of rb1 mutant alleles in tumor and adult tissues was examined to confirm that rb1 
somatic inactivation correlated with brain tumor induction in adult fish (Fig.  4). Targeted rb1 exons 
2 and 3 were sequenced in tumor, retina, muscle and germline tissue from four tumor positive fish 
ranging in age from 3.5 months to one year. In all tumor tissues (4/4) the frequency of rb1 mutant 
Figure 2. rb1 inactivation-induced brain lesions show features of neuroectodermal-like and glial-like 
tumors. (a–f) Histological staining of coronal sections through heads of six adult zebrafish with brain 
tumors. Insets with boxed region refer to region of tumor shown in panel. (a) Neuroectodermal-like 
tumor with neoplastic cells exhibiting small hyperchromatic nuclei that form rosettes (white arrowhead). 
(b) Neuroectodermal-like tumor with neoplastic cells exhibiting oval or wedge shaped nuclei, finely 
granular chromatin, and occasionally forming poorly defined rosettes (black arrowheads). (c) Tumor 
with multilayered tubules (black arrow) formed from cells exhibiting oval or wedge shaped nuclei with 
finely granular chromatin. (d) Glial-like tumor with neoplastic stellate or spindloid cells exhibiting oval or 
irregularly shaped nuclei with granular chromatin forming poorly defined streams and bundles. Numerous 
mitotic figures (white arrowhead) and apoptotic cells (black arrowhead) are present. (e) Presumed mixed 
glial tumor with two cell populations. 1. Small round blue cells with hyperchromatic nuclei frequently in 
clusters (white arrowhead); 2. Larger cells with finely granular chromatin found in small clusters and bands 
(black arrowhead). (f) Expanded glial rests. Multiple small clusters (black arrowhead) and cellular bands of 
cells (black arrow) with round to oval nuclei and finely granular chromatin. no overt mass lesion. Scale bars: 
200 um, inset 20 um.
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Figure 3. Expression of mitotic index, glial and neuronal markers in rb1 inactivation-induced brain 
tumors. H and E staining of coronal sections through wild type brain (a) and a representative rb1 TALEN 
induced brain tumor shows disruption of brain architecture (b). Immunohistochemical analyses on wild 
type (c,f,i,l) and brain tumor tissue (d,e,g,h,j,k,m,n). Phospho-histone pH3 labeling reveals regions of high 
mitotic index throughout the tumor (d,e). Glial marker S100 (g) and neuronal markers HuC/D (j) and SV2 
(m) were detected within brain parenchyma infiltrated with abnormal cells. In the densely cellular regions 
of the tumor a few S100 positive cells were observed (h) while little to no expression of HuC/D (k) and SV2 
(n) was detected. Scale bars in H&E panels 500 um; immunohistochemical panels 50 um.
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alleles was consistently higher than wild type alleles (68%–87% of cloned amplicons represented indels; 
Supplementary Table 1). Only one or two specific rb1 alleles were present in 3 out of 4 tumors. Of the 
10 alleles recovered in the tumor tissue, 8 of the 10 were frameshift mutations. In contrast, the mutation 
frequency in retinal, muscle, and germline tissues was highly variable (3%–100%) and was as high as 
7 different mutant rb1 alleles in one fish (Supplementary Table 1). The presence of predominantly loss 
of function alleles in genetic mosaic fish that develop tumors is consistent with biallelic inactivation of 
rb1 initiating the pathway to transformation. However, the possibility that additional mutations in the 
genome caused by off targeting contributed to tumor induction cannot be ruled out. The high efficiency 
of TALENs targeting rb1 exon 2 produced 19 different indels, with five specific to tumor tissue (Fig. 4a). 
Remarkably, only two exon 3 frameshift alleles, Δ 11 and Δ 19, were recovered in the normal and tumor 
tissues from fish targeted with the low efficiency exon 3 TALENs (Fig. 4b). The high degree of mutagen-
esis was consistent with tumor growth from a neoplastic cell population transformed by inactivation of 
rb1.
In summary, we demonstrate that targeted somatic inactivation of the rb1 tumor suppressor in zebraf-
ish embryos using two independent TALEN pairs results in genetic mosaic adults that develop tumors 
at high frequency, predominantly located in the brain. Pathological and immunohistochemical analy-
ses of the head in affected individuals indicate zebrafish can be predisposed to neuroectodermal-like 
and glial-like tumors by somatic inactivation of rb1 with site-specific nucleases. In contrast to genetic 
mosaic animals, adult rb1–/+ heterozygotes with a stable germline rb1 mutation do not develop tumors. 
This suggests that nuclease targeting induces biallelic inactivation at the rb1 locus and sensitizes cells 
to transformation. It has been proposed that in the case of epithelial cancers, tumor initiating cells may 
arise from a dedifferentiating progenitor population of transit amplifying cells29. Similar mechanisms 
Figure 4. rb1 mutant alleles and allele frequencies in somatic, germline, and tumor tissues from adult 
genetic mosaic zebrafish. (a) 14 different indel alleles in rb1 exon 2 were identified in retina, muscle, and 
germline genomic DNA from two adults. Mutant alleles represented 33% of cloned amplicons. In tumor 
tissue 8 unique alleles were identified, representing 87% of cloned amplicons. (b) Two frameshift alleles that 
delete 11 bp and 19 bp in rb1 exon 3 were detected in two adults. 10% of sequenced clones were mutant in 
retina, muscle or germline tissue. In tumor tissue 68% of sequenced clones were mutant alleles. Red arrows 
mark TALEN cut site.
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may drive neoplasms derived from the neurogenic cell populations in the brain. In support of this, 
mouse models of pediatric and adult brain tumors have been created by targeting tumor suppressor gene 
knockout, oncogene activation and insertional transposon mutagenesis to neural stem and progenitor 
cells in the brain21–26,30–33. Our observations are consistent with previously published zebrafish models 
of brain cancer generated by driving overexpression of activated Ras34,35 in neural and glial progenitor 
cells. Adapting a tissue specific CRISPR targeting method6 to inactivate genes in neural progenitors in 
combination with zebrafish brain cancer models35–37 will be useful for investigating cooperating path-
ways promoting tumorigenesis. Our study demonstrates the potential for rapid large scale screening of 
candidate tumor suppressors in zebrafish using genome-editing nucleases to generate genetic mosaics.
Methods
Zebrafish care and husbandry. Zebrafish were reared in an Aquatic Habitat system from Aquatic 
Ecosystems, Inc., and maintained at 27 oC on a 14 hr light/10 hr dark cycle. The WIK wild type strain 
used in this study was obtained from the Zebrafish International Research Center (http://zebrafish.org/
zirc/home/guide.php). Experimental protocols were approved by the Iowa State University Institutional 
Animal Care and Use Committee (Log # 11-06-6252-I). The protocols are in compliance with American 
Veterinary Medical Association and the National Institutes of Health guidelines for the humane use 
of laboratory animals in research. Adult fish were anesthetized and euthanized in MS-222 Tricaine 
Methanesulfonate, and tissue dissection was carried out according to experimental protocols approved 
by the Iowa State University Institutional Animal Care and Use Committee (Log # 11-06-6252-I) in com-
pliance with the American Veterinary Medical Association and the National Institutes of Health guide-
lines for the humane use of laboratory animals in research. NIH/Office of Animal Care and Use/Animal 
Research Advisory committee (ARAC) Guidelines for endpoint in neoplasia studies (oacu.od.nih.gov/
ARAC/Guidelines for Endpoints in Animal Study Proposals) were used to establish a humane endpoint 
in the zebrafish rb1 TALEN injected fish. Adult fish were monitored for general appearance, size, length, 
viability and morbidity relative to control siblings daily during routine feeding. Fish were closely mon-
itored bi-weekly for gross presentation of cranial tumors. Fish from each injection experiment were 
sacrificed before tumor burden reached 3 mm in size/25 mg in weight, constituting less than 10% of the 
total body weight of an adult fish (300–500 mg), as outlined for mouse and rat studies38, or by 1.5 year 
of age, whichever endpoint was reached first. The swimming behavior of some rb1 TALEN injected fish 
was adversely affected before gross presentation of cranial tumors, possibly due to tumor location. These 
fish were sacrificed although tumor burden was less than 3 mm/10% of body weight.
rb1 TALEN assembly, targeting, and allele analysis. TALENs targeting rb1 exon 2 or exon 3 
were designed using TAL Effector Nucleotide Targeter 2.0 at https://tale-nt.cac.cornell.edu/node/add/
talen-old39 and assembled in the modified GoldyTALEN scaffold5. 150–200 pg of exon 2 or 12.5–50 pg 
of exon 3 TALEN mRNA was injected into 1-cell stage wild type WIK embryos. TALEN efficiency was 
determined by assaying individual injected embryos for disruption of restriction enzyme sites in a PCR 
amplicon spanning the target site. Genomic DNA was extracted from embryos and adult fin clips by plac-
ing tissue in 50 μ l 50 mM NaOH and heating at 95 oC for 30 minutes. For rb1 allele frequency analysis, 
genomic DNA was isolated from tumor, somatic and germline tissues using a DNeasy Blood and Tissue 
Kit (Qiagen). Amplicons were TOPO cloned (Invitrogen), and 50–100 individual clones sequenced per 
sample. Primers used for amplification of rb1 exons: exon 2 F-5’- TTTCCAGACACAAGGACAAGG-3’, 
R-5’-GCGGTAAAGCAGATATCAGAAGA -3’; exon 3 F-5’-TTTCCAGACACAAGGACAAGG-3’, R-5’- 
CCTCACAAGACTGATGAACTGC-3’ or F-5’-TTACCGCACTTGTGTTTTGG-3’, R-5’-TGCCACACAT 
ACCTCAGACC-3’.
Histopathology and Immunohistochemistry. Adult zebrafish were sacrificed and head tissue 
processed for histopathology and immunohistochemistry as described previously40. For histopathology 
tissues fixed in Davidson’s or 10% Formalin (Fisher) were decalcified in Cal-Ex (Fisher), and paraffin 
embedded at the Iowa State University Clinical Histopathology Laboratory. 6 um sections were stained 
with Hematoxylin 7211 Richard-Allan Scientific (Fisher) and 3% Eosin Y (Argos Organics). For immu-
nohistochemistry heads were fixed in 4% paraformaldehyde, decalcified in 12% EDTA, and embedded 
in Tissue-Tek optimal cutting temperature medium (Sakura). 14 um tissue sections were labeled with 
antibodies anti-phosphohistone-H3 (1:100, Upstate), anti-S100 (1:250, Dako). Secondary antibodies 
were conjugated with HRP. Tissues were counterstained with modified Mayer’s Hematoxylin (Fisher) 
and eosin. Slides were photographed on a Zeiss Axiophot using a Nikon Rebel camera and on a Zeiss 
confocal LSM 700.
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